Proresolving lipid mediators and liver disease

Area of Science:

• Hepatology
• Immunology
• Pathology

Background:

• Inflammation is a hallmark of all liver diseases, from early injury to advanced stages.
• Severe inflammation drives multiple organ dysfunction and failure in critical liver conditions.
• Dysregulation of inflammation resolution is linked to chronic inflammatory diseases.

Purpose of the Study:

• To review the inflammatory process in non-alcoholic steatohepatitis (NASH) and acute-on-chronic liver failure (ACLF).
• To highlight the role of specialized pro-resolving mediators in orchestrating inflammation resolution.
• To understand the link between inflammation resolution dysregulation and chronic liver conditions.

Main Methods:

• Literature review focusing on inflammatory processes in NASH and ACLF.
• Analysis of data concerning specialized pro-resolving mediators.
• Examination of the mechanisms driving inflammation and its resolution in liver disease.

Main Results:

• Inflammation is integral across the spectrum of liver disease, impacting severity and outcomes.
• Specialized pro-resolving mediators play a crucial role in controlling and resolving liver inflammation.
• Impaired resolution of inflammation is a common feature in chronic liver diseases like NASH and ACLF.

Conclusions:

• Understanding inflammation and its resolution is vital for managing NASH and ACLF.
• Targeting pro-resolving mediators offers potential therapeutic strategies for liver diseases.
• Further research into inflammation resolution pathways can improve patient outcomes in liver disease.